Endocrinologia
Diretriz preliminar da USPSTF revisa a diretriz anterior e agora recomenda contra iniciar aspirina em baixa dose como prevenção primária de doença cardiovascular (DCV) em pessoas com 60 anos de idade ou mais.
13 Out, 2021 | 13:25hComentários:
Advice shifting on aspirin use for preventing heart attacks – Associated Press
Taking aspirin to prevent heart attack may cause more harm than good, task force says – NPR
Estudos randomizados relacionados:
Randomized Trial: Aspirin for Primary Prevention of Cardiovascular Disease
Randomized Trial: Effects of Aspirin for Primary Prevention in Persons with Diabetes
Randomized Trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
Metanálises relacionadas:
Meta-Analysis: Efficacy and Safety of Aspirin for Primary Prevention of Cardiovascular Events
Opiniões relacionadas:
Aspirin for Primary Prevention: Is This the End of the Road?
Evidence evolving on aspirin as prevention – ACP Internist
Comentário no Twitter
Low Dose Aspirin in the Primary Prevention of Cardiovascular Disease: #USPSTF recommends individualized decision making between 50 and 59 years, and against aspirin use in 60 years+. What a difference a few years can make, with more data and evidence. https://t.co/3nC3jpjTDq pic.twitter.com/SN8K3Z9XJj
— Muin J. Khoury (@MuinJKhoury) October 12, 2021
M-A | Suplementação de ácidos graxos ômega-3 está associada a risco aumentado de fibrilação atrial.
13 Out, 2021 | 13:17hEffect of Long-Term Marine Omega-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis – Circulation (link para o resumo – $ para o texto completo)
Conteúdos relacionados:
Comentário no Twitter
#OriginalResearch Omega-3 fatty acid supplementation is associated with increased risk of #AFib in meta-analysis of RCTs https://t.co/knv0P0lmnC #AHAJournals @bagencer @Hopitaux_unige @CMAlbertEP @CedarsSinai @BrighamWomens @HarvardChanSPH @harvardmed pic.twitter.com/5VIklN8lm8
— Circulation (@CircAHA) October 6, 2021
Revisão | Dieta ótima para a saúde cardiovascular e planetária.
13 Out, 2021 | 13:14hOptimal diet for cardiovascular and planetary health – Heart
Amplo estudo observacional sugere que a gastrectomia vertical pode ser mais segura se comparada ao bypass gástrico em pacientes com obesidade grave.
8 Out, 2021 | 11:43hComparative Safety of Sleeve Gastrectomy and Gastric Bypass Up to 5 Years After Surgery in Patients With Severe Obesity – JAMA Surgery (gratuito por tempo limitado)
Comentários:
Compared to What?—Novel Methods to Approach Randomization for Long-term Bariatric Surgery Outcomes – JAMA Surgery (gratuito por tempo limitado)
Of two common weight loss surgeries, one is safer but less effective – Michigan Medicine
Conteúdos relacionados:
Cohort study: comparing the 5-year diabetes outcomes of sleeve gastrectomy and gastric bypass
Cohort study: interventions and operations 5 years after bariatric surgery
Randomized trial: gastric bypass superior to sleeve gastrectomy for remission of type 2 diabetes
Research: laparoscopic sleeve gastrectomy vs laparoscopic roux-en-y gastric bypass
Comentário no Twitter
Study suggests that the safety benefits of sleeve gastrectomy persist up to 5 years after surgery; this information may help patients and surgeons make informed treatment decisions https://t.co/JuRQGh3byz
— JAMA Surgery (@JAMASurgery) October 6, 2021
Diagnóstico e tratamento dos efeitos colaterais endocrinológicos dos imunoterápicos usados no tratamento do câncer.
8 Out, 2021 | 10:54hConteúdo relacionado: Review: Endocrine complications of immunotherapies
COVID-19 e doença metabólica: mecanismos e abordagem clínica.
5 Out, 2021 | 11:31hConteúdo relacionado: Review | Interplay between endocrinology, metabolism, and COVID-19 infection.
Estudo de coorte | Início de terapia com estatina está associado a risco aumentado de progressão do diabetes.
5 Out, 2021 | 11:20hComentários:
Statin Therapy Initiation and Diabetes Progression – American College of Cardiology
Statin Initiation Linked to Greater Progression of Diabetes – HealthDay
Diabetes progression with initiation of statins – MedicalRessearch.com
Conteúdos relacionados:
Meta-Analysis: Medications that Reduce or Increase the Risk of New Onset Diabetes
Observational Study Points to an Increased Risk of Diabetes Among Patients Using Statins
Cohort Study: Statin Use Associated with a 38% Higher Risk of Incident Type 2 Diabetes
Comentário no Twitter
Large retrospective matched-cohort study found that #statin use was associated with a higher risk of #diabetes treatment escalation and an increased risk of #hyperglycemic complications https://t.co/lFLz7rVfpd
— JAMA Internal Medicine (@JAMAInternalMed) October 4, 2021
Estudo randomizado | Efeitos da dieta cetogênica por 30 dias na composição corporal, força muscular, área muscular e desempenho de jogadores de futebol semiprofissionais.
5 Out, 2021 | 11:12hOMS prioriza o acesso a tratamentos de diabetes e câncer na nova Lista de Medicamentos Essenciais.
4 Out, 2021 | 10:25hComunicado de imprensa: WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists – World Health Organization
Relatório: WHO model list of essential medicines – 22nd list, 2021 – World Health Organization
Comentário: For the first time, WHO committee recommends action on high-priced essential medicines – STAT
Comentário no Twitter (fio – clique para saber mais)
🆕 WHO 2021 Essential Medicines Lists have 20 new medicines for adults & 17 for children, incl. insulin analogues, new oral medicines for diabetes & medicines for cancer treatment https://t.co/LfWwHEZtuM pic.twitter.com/HMFOP8ioBf
— World Health Organization (WHO) (@WHO) October 1, 2021
Relatório de consenso ADA | Tratamento do diabetes tipo 1 em adultos.
4 Out, 2021 | 10:21hComunicado de imprensa: New comprehensive Consensus Report to manage type 1 diabetes launched by major diabetes organisations EASD and ADA – American Associatio of Diabetes
Conteúdo relacionado: Guideline: ADA 2021 Standards of Medical Care in Diabetes
Comentário no Twitter
What a fantastic symposium on the management of #T1D at #EASD2021! Read the full ADA–EASD consensus report here https://t.co/8cEm8N0Enr pic.twitter.com/uMj2R64CkK
— Diabetologia (@DiabetologiaJnl) October 1, 2021


